Literature DB >> 15681163

Targets for indole-3-carbinol in cancer prevention.

Young S Kim1, J A Milner.   

Abstract

Mounting preclinical and clinical evidence indicate that indole-3-carbinol (I3C), a key bioactive food component in cruciferous vegetables, has multiple anticarcinogenic and antitumorigenic properties. Evidence that p21, p27, cyclin-dependent kinases, retinoblastoma, Bax/Bcl-2, cytochrome P-450 1A1 and GADD153 are targets for I3C already exists. Modification of nuclear transcription factors including Sp1, estrogen receptor, nuclear factor kappaB and aryl hydrocarbon receptor may represent a common site of action to help explain downstream cellular responses to dietary I3C and, ultimately, to its anticancer properties. While the current information is intriguing, future I3C research needs to focus on why these changes in nuclear transcription factors occur and how they relate to phenotypic responses and the quantity and duration of exposure to I3C and its dimer 3,3'-diindolylmethane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681163     DOI: 10.1016/j.jnutbio.2004.10.007

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  46 in total

Review 1.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

Review 2.  Targeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapy.

Authors:  Aamir Ahmad; Bernhard Biersack; Yiwei Li; Dejuan Kong; Bin Bao; Rainer Schobert; Subhash B Padhye; Fazlul H Sarkar
Journal:  Anticancer Agents Med Chem       Date:  2013-09       Impact factor: 2.505

3.  Purple head broccoli (Brassica oleracea L. var. italica Plenck), a functional food crop for antioxidant and anticancer potential.

Authors:  Ashun Chaudhary; Sonika Choudhary; Upendra Sharma; Adarsh Pal Vig; Bikram Singh; Saroj Arora
Journal:  J Food Sci Technol       Date:  2018-03-08       Impact factor: 2.701

4.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 5.  Natural compounds as anticancer agents: Experimental evidence.

Authors:  Jiao Wang; Yang-Fu Jiang
Journal:  World J Exp Med       Date:  2012-06-20

Review 6.  Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Authors:  Gary L Firestone; Shyam N Sundar
Journal:  Mol Endocrinol       Date:  2009-10-16

7.  Indole-3-carbinol triggers aryl hydrocarbon receptor-dependent estrogen receptor (ER)alpha protein degradation in breast cancer cells disrupting an ERalpha-GATA3 transcriptional cross-regulatory loop.

Authors:  Crystal N Marconett; Shyam N Sundar; Kevin M Poindexter; Theresa R Stueve; Leonard F Bjeldanes; Gary L Firestone
Journal:  Mol Biol Cell       Date:  2010-02-03       Impact factor: 4.138

8.  The role of estrogen receptor β in transplacental cancer prevention by indole-3-carbinol.

Authors:  Abby D Benninghoff; David E Williams
Journal:  Cancer Prev Res (Phila)       Date:  2013-02-27

9.  OSU-A9, a potent indole-3-carbinol derivative, suppresses breast tumor growth by targeting the Akt-NF-kappaB pathway and stress response signaling.

Authors:  Jing-Ru Weng; Chen-Hsun Tsai; Hany A Omar; Aaron M Sargeant; Dasheng Wang; Samuel K Kulp; Charles L Shapiro; Ching-Shih Chen
Journal:  Carcinogenesis       Date:  2009-08-25       Impact factor: 4.944

10.  Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol.

Authors:  Yoshiaki Machijima; Chie Ishikawa; Shigeki Sawada; Taeko Okudaira; Jun-nosuke Uchihara; Yuetsu Tanaka; Naoya Taira; Naoki Mori
Journal:  Retrovirology       Date:  2009-01-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.